⌘K

Login Start Free

Home/Filings/4/0001179110-22-000545

4//SEC Filing

Galle Liz 4

Accession 0001179110-22-000545

CIK 0001235912other

View on SEC.gov Company Profile

Filed

Jan 19, 7:00 PM ET

Accepted

Jan 20, 6:14 PM ET

Size

5.3 KB

Accession

0001179110-22-000545

Insider Transaction Report

Form 4

Period: 2022-01-18

VP of Global Clinical Research

Transactions

Award
Stock Option (right to buy)
2022-01-18+25,900→ 25,900 total
Exercise: $9.08Exp: 2032-01-17→ Common Stock (25,900 underlying)

Footnotes (1)

[F1]Vests as to 25% of the shares on January 18, 2023 and as to 1/48th of the shares each month thereafter.

Documents

1 file

4
edgar.xmlPrimary
FORM 4 -

Issuer

CVRx, Inc.

CIK 0001235912

Entity typeother

Related Parties

1

filerCIK 0001869353

Filing Metadata

Form type: 4
Filed: Jan 19, 7:00 PM ET
Accepted: Jan 20, 6:14 PM ET
Size: 5.3 KB

View on SEC.gov